Monday, September 26, 2022
wellness India Expo
Home Tags Drug Controller

Tag: Drug Controller

Zydus’s COVID-19 drug ‘Virafin’ gets DCGI nod

91.15% of patients treated with PegIFN were RT PCR negative by day 7. A single dose of the antiviral Virafin administered subcutaneously early on shows significant clinical and virological improvement in moderate COVID-19 adult patients.......................

Top govt bodies hold workshop on regulatory compliance to accelerate innovations

The National workshop on regulatory compliance for accelerating innovations held on 9th April, at the Centre for Cellular And Molecular Platforms (C-CAMP), Bengaluru, was one of the six national programs planned across the nation.................

Significant reduction in cancer drug prices due to trade margin capping

The National Pharmaceutical Pricing Authority, in its meeting on 26th February, 2019, invoked extraordinary powers in public interest, under Para 19 of the Drugs (Prices Control) Order, 2013 to bring 42 non-scheduled anti-cancer drugs under price control...…………..

DCGI’s green signal to Mylan’s launch of Avonza in India

The new drug by Mylan offers an innovative, reduced-dose alternative first-line regimen for people being treated for HIV/AIDS in India.........

ISCR launches causality assessment portal for compensation

Dr Soumya Swaminathan, DG, Indian Council for Medical Research, delivered a special talk at the10th Annual Clinical Research Conference at the Indian Society for Clinical Research.....